Olle Ringdén

56.3k total citations · 10 hit papers
680 papers, 39.3k citations indexed

About

Olle Ringdén is a scholar working on Hematology, Immunology and Oncology. According to data from OpenAlex, Olle Ringdén has authored 680 papers receiving a total of 39.3k indexed citations (citations by other indexed papers that have themselves been cited), including 427 papers in Hematology, 177 papers in Immunology and 137 papers in Oncology. Recurrent topics in Olle Ringdén's work include Hematopoietic Stem Cell Transplantation (398 papers), Mesenchymal stem cell research (93 papers) and Cytomegalovirus and herpesvirus research (88 papers). Olle Ringdén is often cited by papers focused on Hematopoietic Stem Cell Transplantation (398 papers), Mesenchymal stem cell research (93 papers) and Cytomegalovirus and herpesvirus research (88 papers). Olle Ringdén collaborates with scholars based in Sweden, United States and Germany. Olle Ringdén's co-authors include Katarina Le Blanc, Berit Sundberg, Mats Remberger, Per Ljungman, Ida Rasmusson, Mehmet Uzunel, Jonas Mattsson, Cecilia Götherström, B Lönnqvist and Moustapha Hassan and has published in prestigious journals such as New England Journal of Medicine, The Lancet and JAMA.

In The Last Decade

Olle Ringdén

678 papers receiving 38.2k citations

Hit Papers

Treatment of severe acute graft-versus-host disease w... 1990 2026 2002 2014 2004 1990 2008 2003 2003 500 1000 1.5k 2.0k
What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

  1. Treatment of severe acute graft-versus-host disease with third party haploidentical mesenchymal stem cells
    2004 2.1k citations Katarina Le Blanc, Berit Sundberg et al. The Lancet profile →
  2. Graft-versus-leukemia reactions after bone marrow transplantation
    1990 2.1k citations Olle Ringdén, B Speck et al. Blood profile →
  3. Mesenchymal stem cells for treatment of steroid-resistant, severe, acute graft-versus-host disease: a phase II study
    2008 2.0k citations Katarina Le Blanc, Franco Locatelli et al. The Lancet profile →
  4. HLA expression and immunologic propertiesof differentiated and undifferentiated mesenchymal stem cells
    2003 1.3k citations Katarina Le Blanc, Olle Ringdén et al. profile →
  5. Mesenchymal Stem Cells Inhibit and Stimulate Mixed Lymphocyte Cultures and Mitogenic Responses Independently of the Major Histocompatibility Complex
    2003 1.1k citations Katarina Le Blanc, Berit Sundberg et al. Scandinavian Journal of Immunology profile →
  6. Mesenchymal Stem Cells for Treatment of Therapy-Resistant Graft-versus-Host Disease
    2006 893 citations Olle Ringdén, Mehmet Uzunel et al. profile →
  7. Immunomodulation by mesenchymal stem cells and clinical experience
    2007 557 citations Katarina Le Blanc, Olle Ringdén profile →
  8. Mesenchymal stem cells inhibit the formation of cytotoxic T lymphocytes, but not activated cytotoxic T lymphocytes or natural killer cells
    2003 519 citations Olle Ringdén, Berit Sundberg et al. profile →
  9. Analysis of Tissues Following Mesenchymal Stromal Cell Therapy in Humans Indicates Limited Long-Term Engraftment and No Ectopic Tissue Formation
    2012 425 citations Guido Moll, Berit Sundberg et al. profile →
  10. Intravascular Mesenchymal Stromal/Stem Cell Therapy Product Diversification: Time for New Clinical Guidelines
    2019 295 citations Guido Moll, Olle Ringdén et al. profile →

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Olle Ringdén Sweden 91 18.2k 14.7k 9.4k 7.7k 7.0k 680 39.3k
Éliane Gluckman France 93 19.2k 1.1× 6.9k 0.5× 7.8k 0.8× 6.5k 0.8× 2.5k 0.4× 627 29.5k
Franco Locatelli Italy 88 12.5k 0.7× 8.1k 0.6× 9.9k 1.1× 8.4k 1.1× 3.2k 0.5× 1.0k 33.0k
Richard E. Champlin United States 113 27.2k 1.5× 8.4k 0.6× 12.6k 1.3× 14.9k 1.9× 2.3k 0.3× 1.1k 45.3k
Andrea Bacigalupo Italy 83 18.3k 1.0× 6.8k 0.5× 6.6k 0.7× 6.7k 0.9× 2.6k 0.4× 592 26.3k
Rainer Storb United States 126 48.8k 2.7× 11.9k 0.8× 19.1k 2.0× 15.7k 2.0× 5.1k 0.7× 1.1k 67.2k
Daniel J. Weisdorf United States 96 24.2k 1.3× 5.1k 0.3× 13.3k 1.4× 11.4k 1.5× 2.2k 0.3× 732 38.4k
Gèrard Socié France 91 18.7k 1.0× 4.8k 0.3× 9.2k 1.0× 7.4k 1.0× 2.0k 0.3× 701 30.2k
Arnon Nagler Israel 88 21.6k 1.2× 6.0k 0.4× 12.6k 1.3× 12.5k 1.6× 2.4k 0.3× 1.1k 39.3k
Hillard M. Lazarus United States 76 13.4k 0.7× 5.9k 0.4× 3.9k 0.4× 7.0k 0.9× 2.3k 0.3× 545 25.8k
Bruce R. Blazar United States 119 20.2k 1.1× 5.0k 0.3× 36.0k 3.8× 16.5k 2.2× 3.7k 0.5× 843 58.3k

Countries citing papers authored by Olle Ringdén

Since Specialization
Citations

This map shows the geographic impact of Olle Ringdén's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Olle Ringdén with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Olle Ringdén more than expected).

Fields of papers citing papers by Olle Ringdén

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Olle Ringdén. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Olle Ringdén. The network helps show where Olle Ringdén may publish in the future.

Co-authorship network of co-authors of Olle Ringdén

This figure shows the co-authorship network connecting the top 25 collaborators of Olle Ringdén. A scholar is included among the top collaborators of Olle Ringdén based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Olle Ringdén. Olle Ringdén is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Ringdén, Olle, Elham Roshandel, Mohammad Mahdi Majidi, et al.. (2022). Conquering the Cytokine Storm in COVID-19 Induced ARDS Using Placenta-Derived Decidua Stromal Cells. Transplantation and Cellular Therapy. 28(3). S222–S222. 1 indexed citations
2.
Legert, Karin Garming, Olle Ringdén, Mats Remberger, et al.. (2020). Oral mucositis after tacrolimus/sirolimus or cyclosporine/methotrexate as graft‐versus‐host disease prophylaxis. Oral Diseases. 27(5). 1217–1225. 7 indexed citations
3.
Moll, Guido, Lech Ignatowicz, Rusan Catar, et al.. (2015). Different Procoagulant Activity of Therapeutic Mesenchymal Stromal Cells Derived from Bone Marrow and Placental Decidua. Stem Cells and Development. 24(19). 2269–2279. 99 indexed citations
4.
Kaipe, Helen, Tom Erkers, Silvia Nava, et al.. (2015). Immunogenicity of Decidual Stromal Cells in an Epidermolysis Bullosa Patient and in Allogeneic Hematopoietic Stem Cell Transplantation Patients. Stem Cells and Development. 24(12). 1471–1482. 17 indexed citations
5.
Kaipe, Helen, Tom Erkers, Behnam Sadeghi, & Olle Ringdén. (2014). Stromal cells–are they really useful for GVHD?. Bone Marrow Transplantation. 49(6). 737–743. 30 indexed citations
6.
Luger, Selina M., Olle Ringdén, M-J Zhang, et al.. (2011). Similar outcomes using myeloablative vs reduced-intensity allogeneic transplant preparative regimens for AML or MDS. Bone Marrow Transplantation. 47(2). 203–211. 194 indexed citations
7.
Uhlin, Michael, Darius Sairafi, Sofia Berglund, et al.. (2011). Mesenchymal Stem Cells Inhibit Thymic Reconstitution After Allogeneic Cord Blood Transplantation. Stem Cells and Development. 21(9). 1409–1417. 24 indexed citations
8.
Ringdén, Olle & Katarina Le Blanc. (2011). Mesenchymal stem cells for treatment of acute and chronic graft-versus-host disease, tissue toxicity and hemorrhages. Best Practice & Research Clinical Haematology. 24(1). 65–72. 71 indexed citations
9.
Shaw, Bronwen E., Theodore A. Gooley, Mari Malkki, et al.. (2007). The importance of HLA-DPB1 in unrelated donor hematopoietic cell transplantation. Blood. 110(13). 4560–4566. 134 indexed citations
10.
Barrett, A. John, Olle Ringdén, Mei‐Jie Zhang, et al.. (2000). Effect of nucleated marrow cell dose on relapse and survival in identical twin bone marrow transplants for leukemia.. Blood. 95(11). 3323–3327. 66 indexed citations
11.
Remberger, Mats, Olle Ringdén, Per Ljungman, et al.. (1998). Booster marrow or blood cells for graft failure after allogeneic bone marrow transplantation. Bone Marrow Transplantation. 22(1). 73–78. 44 indexed citations
12.
Ljungman, Per, H Hägglund, B. Björkstrand, B Lönnqvist, & Olle Ringdén. (1997). Peroperative teicoplanin for prevention of gram-positive infections in neutropenic patients with indwelling central venous catheters: a randomized, controlled study. Supportive Care in Cancer. 5(6). 485–488. 43 indexed citations
13.
Ljungman, Per, et al.. (1997). High busulfan concentrations are associated with increased transplant-related mortality in allogeneic bone marrow transplant patients. Bone Marrow Transplantation. 20(11). 909–913. 104 indexed citations
14.
Ek, Sverker, et al.. (1996). Cytokine Stimulation of Human Fetal Hematopoietic Cells. Fetal Diagnosis and Therapy. 11(5). 318–325. 2 indexed citations
15.
Tollemar, J, et al.. (1994). Fungal prophylaxis with AmBisome in liver and bone marrow transplant recipients: results of two randomized double-blind studies.. PubMed. 26(3). 1833–1833. 30 indexed citations
16.
Gratama, Jan W., M. A. P. Oosterveer, Willem E. Fibbe, et al.. (1992). Epstein-Barr virus infection in allogeneic marrow grafting: lessons for transplant physicians and virologists. Annals of Hematology. 64(S1). A162–A165. 8 indexed citations
17.
Ringdén, Olle, Berit Sundberg, L Markling, & J Tollemar. (1987). Polyclonal Antibody Secretion during Acute Graft‐versus‐Host Disease. Scandinavian Journal of Immunology. 26(5). 469–476. 3 indexed citations
18.
Barrett, A. John, Éliane Gluckman, Steven J. Jacobsen, et al.. (1987). BONE-MARROW TRANSPLANTATION IN HIGH-RISK ACUTE LYMPHOBLASTIC LEUKAEMIA IN FIRST AND SECOND REMISSION. The Lancet. 329(8536). 786–789. 57 indexed citations
19.
Heimdahl, Anders, et al.. (1985). Oral condition of patients with leukemia and severe aplastic anemia. Oral Surgery Oral Medicine Oral Pathology. 60(5). 498–504. 48 indexed citations
20.
Ringdén, Olle, et al.. (1977). The effects of anti-lymphocyte globulin on lymphocyte subpopulations in recipients of kidney allografts.. Munich Personal RePEc Archive (Ludwig Maximilian University of Munich). 86–9. 3 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Éliane Gluckman Breakdown of academic impact, for papers by Franco Locatelli Breakdown of academic impact, for papers by Richard E. Champlin Breakdown of academic impact, for papers by Andrea Bacigalupo Breakdown of academic impact, for papers by Rainer Storb Breakdown of academic impact, for papers by Daniel J. Weisdorf Breakdown of academic impact, for papers by Gèrard Socié Breakdown of academic impact, for papers by Arnon Nagler Breakdown of academic impact, for papers by Hillard M. Lazarus Breakdown of academic impact, for papers by Bruce R. Blazar
Rankless by CCL
2026